{"name":"Changchun BCHT Biotechnology Co.","slug":"changchun-bcht-biotechnology-co","ticker":"","exchange":"","domain":"changchunbchtbiotechnology.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DTacP-IPV/Hib","genericName":"DTacP-IPV/Hib","slug":"dtacp-ipv-hib","indication":"Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"DTacP","genericName":"DTacP","slug":"dtacp","indication":"Solid tumors (specific indication under investigation in phase 3)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Herpes Zoster Vaccine, Live","genericName":"Herpes Zoster Vaccine, Live","slug":"herpes-zoster-vaccine-live","indication":"Prevention of herpes zoster (shingles) in adults with prior varicella infection","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"live attenuated zoster vaccine","genericName":"live attenuated zoster vaccine","slug":"live-attenuated-zoster-vaccine","indication":"Prevention of herpes zoster (shingles)","status":"phase_3"}]}],"pipeline":[{"name":"DTacP-IPV/Hib","genericName":"DTacP-IPV/Hib","slug":"dtacp-ipv-hib","phase":"phase_3","mechanism":"DTacP-IPV/Hib is a combination vaccine that provides immunization against diphtheria, tetanus, acellular pertussis, poliomyelitis, and Haemophilus influenzae type b through inactivated antigens and toxoids.","indications":["Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"DTacP","genericName":"DTacP","slug":"dtacp","phase":"phase_3","mechanism":"DTacP is a diphtheria toxin-based immunotoxin that targets and eliminates cells expressing specific tumor-associated antigens.","indications":["Solid tumors (specific indication under investigation in phase 3)"],"catalyst":""},{"name":"Herpes Zoster Vaccine, Live","genericName":"Herpes Zoster Vaccine, Live","slug":"herpes-zoster-vaccine-live","phase":"marketed","mechanism":"This live attenuated vaccine stimulates the immune system to recognize and respond to varicella-zoster virus, preventing herpes zoster (shingles) reactivation.","indications":["Prevention of herpes zoster (shingles) in adults with prior varicella infection"],"catalyst":""},{"name":"live attenuated zoster vaccine","genericName":"live attenuated zoster vaccine","slug":"live-attenuated-zoster-vaccine","phase":"phase_3","mechanism":"The live attenuated zoster vaccine works by introducing a weakened form of the varicella-zoster virus to stimulate an immune response.","indications":["Prevention of herpes zoster (shingles)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1rQnJGN2RFYXZKcGVPeWlMSUtGRVJnRHdxOGlGc1RMOGt3N01Za2N0LUtoLUg2LU9FNng3WFhXdlRPYXFTTkNVMW14QmpPZWcxM0VnZ180QXV2NkplNFFTZ0t3?oc=5","date":"2025-10-24","type":"pipeline","source":"HKTDC Research","summary":"Biomedicine Boost As Zhuhai Links Up With Hong Kong and Macao - HKTDC Research","headline":"Biomedicine Boost As Zhuhai Links Up With Hong Kong and Macao","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNZVZiUlRIdm1DQTZrY21yQThwVmE2bnpOZ01ENDk5bWp6LTNVTXJDNkxQbkVHeDRSZmFtLTVQT2h0TG5wdkhYNGNJSzhNNGhxNWxvRHZQb0w4Y2dyRzdXZXZCLXdVR2tGRDMwNnBLZk1paVJ2ZUxwc2pudFNiRmhOTHMwU2wwUTZmUElqM2NhSzl4a03SAZgBQVVfeXFMTUpCdnpIMk4yVzBoSFFuTjROdXJURnBrbUs3bEQ1bjhWWE83R2hLTl9sa2pxVk0yQ0M5SHFYQklwMWlBNnYzYVY3VVFjSUtZeTZ1ZmxHLWNuaGlXcDRrSzVBM0V4YXpRcUxoNnRFdUpmUEhLTlJzQTlNOHNkZzBnSkdlZXRscll3b01PSjhVVklBX2xuQ2YxNU0?oc=5","date":"2025-09-16","type":"pipeline","source":"Global Market Insights Inc.","summary":"Varicella Zoster Virus Infection Treatment Market size to cross USD 2.69 Billion by 2034 - Global Market Insights Inc.","headline":"Varicella Zoster Virus Infection Treatment Market size to cross USD 2.69 Billion by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPckpteW9zVENGWE1yX0pDVGVIbHJOZnF0blBSdDlZci1KNWpoS0RrQzQxc1ZzZFByc0NNbEdEQWhRcTFpYUQ0VmRxU1lZTU9MUlJvNFc2ZGpCenpZaHdZNXhEQWZHM0Z6ZkJUVkl6SlBqaE5FdlhEUlJFd3JManVPc0xDUGN6Z2dGMm9fV2FCdWphY3hVdDZNemVrVjJ2Rlk?oc=5","date":"2025-08-19","type":"trial","source":"BioWorld News","summary":"Luzhu’s shingles vaccine outperforms Shingrix in phase III - BioWorld News","headline":"Luzhu’s shingles vaccine outperforms Shingrix in phase III","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPYWQySFZNMzJhYXZDUFdDQ1AwNTVtUFdyZXdqYW42WkdDaWg3Y01SVlZGUkpzZUFPM3VPbUZuX2pXTXJlYXc4bDN1ZlJUNjJFV2lVX1JWSjE0akxJcGxWRlJFUFc5c0tsTDcwenlUUm0xSXhvV0Zza20xTXV0RHJVd3RodmowbDIyTFdVNmI1M0Uxd0RXNk41RXl5d1MtTklZcHpBRDVtWVIwUG1URVowbTE2MFBoR24wX2c?oc=5","date":"2024-12-05","type":"deal","source":"Fierce Pharma","summary":"GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal - Fierce Pharma","headline":"GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxObzFYejRxZDVHaGNSTDNXMXF0R19DZ0pyWjh1OHFheWdIYWRoNXdUQ1pBNjBkYlh5cEJwWmhSaHljb0g5VzBJUjlsNWZseWIzUDZZd29wYU10dWNCZThqdmtWa3JOR0NOQWR1dW5mT3hKZGM1NDktMjFkVWdYVi1JeENrNVotaUJ0bER5Rkt4Zw?oc=5","date":"2024-11-06","type":"trial","source":"Yahoo Finance","summary":"Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight - Yahoo Finance","headline":"Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNaHdDbjVnVXNjNlE1d3dJcHhMWDg2TVMzMDFVb3lYaW9Qd0ZXRUFJbzNEZlhnQ1pDVVhhbUNRWVNNUXFRRF8tMjk1X3B5X1dmMWlaalZvV1Z4OVNMWWxIYl9NTExvRTZXWW80RDBwUzUyUERFemlTY3pCb1F6VjhLQTk1WjdwbFVjZ1FsMEV3bGt0bTNsX0lRMXdzNnhFSUpfMFhLUWh6OExMWUsxNXpnN0xXUQ?oc=5","date":"2023-07-11","type":"earnings","source":"Yicai Global","summary":"China’s BCHT Biotech Expects First-Half Profit to Soar Up to 63% on New Herpes Jab - Yicai Global","headline":"China’s BCHT Biotech Expects First-Half Profit to Soar Up to 63% on New Herpes Jab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1kRnV4d1NIaDl0aXJ0M0hUMFlseXNVaVlqbDFRZ2lySHE0dndPSTdZMGlmdVEtVUlSYlJJYTRRcEo2ZzhDNHVmTksyOUl0Z3FvSEF5aEttNzJHT21YdWk5RjE2dG5GeHpCcUN0RWIxUFNEX1hv?oc=5","date":"2017-09-07","type":"pipeline","source":"Allied Market Research","summary":"Varicella Live Vaccine Market Size & Share | Growth Analysis by 2026 - Allied Market Research","headline":"Varicella Live Vaccine Market Size & Share | Growth Analysis by 2026","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}